Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial

View ORCID ProfileMaría Elvira Balcells, View ORCID ProfileLuis Rojas, View ORCID ProfileNicole Le Corre, View ORCID ProfileConstanza Martínez-Valdebenito, View ORCID ProfileMaría Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, View ORCID ProfileRicardo Castro, View ORCID ProfileMauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, View ORCID ProfilePatricio Ross, View ORCID ProfileJaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, View ORCID ProfileRicardo Soto-Rifo, View ORCID ProfileFernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, View ORCID ProfileCarlos Balmaceda, View ORCID ProfileManuel A. Espinoza, Jaime Pereira, Bruno Nervi
doi: https://doi.org/10.1101/2020.09.17.20196212
María Elvira Balcells
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Elvira Balcells
  • For correspondence: ebalcells@uc.cl
Luis Rojas
2Department of Internal Medicine. School of Medicine. Pontificia Universidad Católica de Chile
3Program of Pharmacology and Toxicology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis Rojas
Nicole Le Corre
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicole Le Corre
Constanza Martínez-Valdebenito
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Constanza Martínez-Valdebenito
María Elena Ceballos
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Elena Ceballos
Marcela Ferrés
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayling Chang
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Vizcaya
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastián Mondaca
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Álvaro Huete
7Department of Radiology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Castro
8Department of Intensive Care Medicine. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo Castro
Mauricio Sarmiento
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mauricio Sarmiento
Luis Villarroel
9Department of Public Health. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandra Pizarro
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricio Ross
2Department of Internal Medicine. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricio Ross
Jaime Santander
10Department of Psychiatry. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jaime Santander
Barbara Lara
11Emergency Medicine Section. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcela Ferrada
12Clinical Research Center. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergio Vargas-Salas
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Beltrán-Pavez
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Soto-Rifo
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo Soto-Rifo
Fernando Valiente-Echeverría
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando Valiente-Echeverría
Christian Caglevic
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricio Mahave
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Selman
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raimundo Gazitúa
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Luis Briones
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Villarroel-Espindola
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
15Translational Medicine Research Laboratory. Fundación Arturo López Pérez (FALP) Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Balmaceda
16Health Technology Assessment Unit, Clinical Research Center, School of Medicine, Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Balmaceda
Manuel A. Espinoza
9Department of Public Health. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel A. Espinoza
Jaime Pereira
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Nervi
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Convalescent plasma (CP), despite limited evidence on its efficacy, is being widely used as a compassionate therapy for hospitalized patients with COVID-19. We aimed to evaluate the efficacy and safety of early CP therapy in COVID-19 progression.

Methods Open-label, single-center, randomized clinical trial performed in an academic center in Santiago, Chile from May 10, 2020, to July 18, 2020, with final follow-up August 17, 2020. The trial included patients hospitalized within the first 7 days of COVID-19 symptoms onset, presenting risk factors for illness progression and not on mechanical ventilation. The intervention consisted in immediate CP (early plasma group) versus no CP unless developing pre-specified criteria of deterioration (deferred plasma group). Additional standard treatment was allowed in both arms. The primary outcome was a composite of mechanical ventilation, hospitalization for >14 days or death. Key secondary outcomes included: time to respiratory failure, days of mechanical ventilation, hospital length-of-stay, mortality at 30 days, and SARS-CoV-2 RT-PCR clearance rate.

Results Of 58 randomized patients (mean age, 65.8 years, 50% male), 57 (98.3%) completed the trial. A total of 13 (43.3%) participants from the deferred group received plasma based on clinical aggravation. We found no benefit in the primary outcome (32.1% vs 33.3%, OR 0.95, 95% CI 0.32-2.84, p>0.99) in the early versus deferred CP group. In-hospital mortality rate was 17.9% vs 6.7% (OR 3.04, 95% CI 0.54-17.2, p=0.25), mechanical ventilation 17.9% vs 6.7% (OR 3.04, 95% CI 0.54-17.2, p=0.25), and prolonged hospitalization 21.4% vs 30% (OR 0.64, 95%CI, 0.19-2.1, p=0.55) in early versus deferred CP group, respectively. Viral clearance rate on day 3 (26% vs 8%, p=0.20) and day 7 (38% vs 19%, p=0.37) did not differ between groups. Two patients experienced serious adverse events within 6 or less hours after plasma transfusion.

Conclusion Immediate addition of CP therapy in early stages of COVID-19 -compared to its use only in case of patient deterioration-did not confer benefits in mortality, length of hospitalization or mechanical ventilation requirement.

Clinical Trials Registration NCT04375098

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04375098

Funding Statement

This work was supported by a grant from Fondo de Adopción Tecnológica SiEmpre, SOFOFA Hub, and Ministerio de Ciencia, Tecnología Conocimiento e Innovación Chile.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Review Board of the Pontificia Universidad Católica de Chile.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The full data that support the findings of this study are available from the corresponding author, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, Ricardo Castro, Mauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel A. Espinoza, Jaime Pereira, Bruno Nervi
medRxiv 2020.09.17.20196212; doi: https://doi.org/10.1101/2020.09.17.20196212
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, Ricardo Castro, Mauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel A. Espinoza, Jaime Pereira, Bruno Nervi
medRxiv 2020.09.17.20196212; doi: https://doi.org/10.1101/2020.09.17.20196212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)